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Serum fibroblast growth factor 23 (FGF23) is a novel
phosphaturic factor and important for the regulation of
inorganic phosphate (Pi) homeostasis. In this study, we
examined an acute effect of oral Pi loading on serum FGF23
levels to clarify the role in rapid adjustment of serum Pi level.
We performed a randomized, double-blind, crossover study
in eight healthy male volunteers. The subjects were
alternately served one of three test meals containing
different Pi amounts (400 mg (P400), 800 mg (P800), and
1200 mg (P1200)) as lunch at noon. The postprandial changes
in serum levels of Pi, Ca, 1,25-dihydroxyvitamin D,
intact-parathyroid hormone (iPTH), intact-FGF23 (iFGF23),
and urinary excretion of Pi and Ca until 8 h after Pi loading
were estimated. Serum Pi levels and urinary Pi excretion
significantly increased within 1 h after P400 and P800 intake.
Serum iPTH levels at 1–2 and 4–6 h after P1200 intake was
significantly higher than those of P400 intake. Serum iFGF23
levels slightly decreased up to 8 h after P400 intake and up to
6 h after P800 intake, but not changed in P1200 intake.
Significant increase of iFGF23 was observed at 8 h after
P1200 intake compared with both P400 and P800 intake.
Additionally, negative association was detected between
iFGF23 and serum Pi, whereas positive association was
observed between iPTH and serum Pi during the short
period. We conclude that oral Pi loading cannot rapidly
increase serum FGF23 level. FGF23 may be not associated
with rapid adaptation of Pi homeostasis.
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Inorganic phosphate (Pi) is an essential nutrient for many
biological processes, including skeletal mineralization and
energy metabolism. Serum Pi level is maintained within a
narrow range through a complex interplay between intestinal
absorption and renal excretion of Pi. These processes are
primarily regulated by parathyroid hormone (PTH) and
1,25-dihydroxyvitamin D (1,25(OH)2D).
1–3 However, PTH
and 1,25(OH)2D act predominantly to control Ca home-
ostasis, and Pi homeostasis often undergoes changes as a
result. Therefore, the regulation of Pi homeostasis is not
clearly understood despite its broad biological importance.
Recently, emerging evidence suggests that there are other
factors of bone origin that participate in maintaining Pi
homeostasis, such as fibroblast growth factor 23 (FGF23),4
matrix extracellular phosphoglycoprotein,5 and frizzled-
related protein-4.6 Among these factors, FGF23 has been
shown to be associated with the hypophosphatemic diseases,
including autosomal-dominant hypophosphatemic rickets,
tumor-induced osteomalacia, and X-linked hypophosphate-
mic rickets.7–9 Shimada et al.10 have reported that adminis-
tration of the recombinant FGF23 protein reduced serum Pi
without affecting serum calcium, and also increased renal Pi
excretion in mice. They also reported that serum 1,25(OH)2D
levels decreased within 3 h after a rapid bolus injection of
recombinant FGF23, whereas reductions in serum Pi
concentrations first appeared at 8–9 h after the injection.11
Furthermore, in patients with tumor-induced osteomalacia,
elevated FGF23 levels rapidly decreased after removal of the
responsible tumor, and serum levels of Pi and 1,25(OH)2D
increased following the decrease in FGF23.12–14 These reports
indicate that FGF23 strongly suppresses 1,25(OH)2D pro-
duction and elicits hypophosphatemia.
On the other hand, hyperphosphatemic patients with
chronic kidney disease showed significant elevation in
circulating FGF23, which correlated with serum Pi and
creatinine (CRE) levels,12,15,16 suggesting a possible feedback
system in which serum FGF23 regulates Pi in response to
serum Pi levels. Saito et al.17 demonstrated that a dietary Pi
loading for 4 weeks led to hyperphosphatemia and increased
serum FGF23 levels in 5/6 nephrectomized rats. In normal
mice, serum FGF23 levels were regulated by serum Pi
controlled by dietary Pi loading for 5 days.18 Furthermore,
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Ferrari et al.19 showed that FGF23 was implicated in the
physiological regulation of Pi homeostasis independent of
PTH, particularly in response to a dietary Pi loading for 5
days in humans. These findings suggest that serum FGF23
levels increase in response to several days of a high Pi diet
and/or by continuous elevation of serum Pi levels.
Dietary Pi also acutely controls renal Pi reabsorption.1,3 In
rats, Martin et al.20 have documented that oral Pi loading can
regulate plasma PTH levels within minutes. Both PTH and
FGF23 inhibit proximal tubule Pi reabsorption, resulting in
the lowering of serum Pi levels. If FGF23 plays an important
role in Pi regulation, FGF23 could be rapidly secreted to
adapt to dietary Pi changes. In this study, we investigated the
acute response of FGF23 to oral Pi loading in healthy men
with an assay system for intact-FGF23 (iFGF23) (Table 1 and
Figure 1).
RESULTS
Measurement of serum Pi level and urinary Pi excretion
Serum Pi levels increased slightly after ingestion of the meal
containing normal amounts of Pi (P400) (Figure 2a).
Ingestion of the P800 and P1200 meals prolonged the
significantly higher in serum Pi levels from 0.5 h until the end
of the experiment compared to that of the P400 meal. Serum
Pi levels from 1 to 6 h following the P1200 meal were also
significantly higher than those following the P800 meal
(Figure 2a). The area under the curve (AUC) for serum Pi
calculated over 8 h markedly increased as the intake of Pi
increased. The AUCs after P800 (444744 mg min/ml) and
P1200 (519738 mg min/ml) meals were significantly greater
than that after the P400 meal (217756 mg min/ml)
Table 1 | Individual baseline characteristics of subjects
Subjects
A B C D E F G H
Age (years) 22 20 21 21 20 34 23 21
Height (cm) 172 168 168 176 173 171 169 173
Weight (kg) 64.2 63.1 60.0 64.9 47.8 64.9 57.5 68.2
Serum Ca (mg/dl) 9.4 10.4 9.0 9.3 9.1 9.3 9.7 9.5
Serum Pi (mg/dl) 3.2 3.1 3.8 3.9 3.4 2.7 3.4 3.4
Serum iPTH (pg/ml) 23 31 20 23 22 28 18 22
Serum 25(OH)D (ng/ml) 31 25 25 25 27 24 31 25
Serum 1,25(OH)2D (pg/ml) 41 83 55 83 62 69 72 57
Serum iFGF23 (pg/ml) 37 32 27 26 40 10 13 33
Serum creatinine (mg/dl) 1.1 1.1 1.0 1.0 1.1 0.9 1.1 1.0
Blood glucose (mg/dl) 85 85 61 78 80 76 79 86
1,25(OH)2D, 1,25-dihydroxyvitamin D; iFGF23, intact-fibroblast growth factor 23; iPTH, intact-parathyroid hormone; Pi, inorganic phosphate.
Appointed water only Water loading (100 ml/h)
Test meal
Dinner
Urine collection
for Pi, Ca, CRE
Blood collection
for Pi, Ca, CRE, iFGF23
for iPTH, 1,25(OH)2D
Breakfast
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P400
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Figure 1 | Study schema. The three test meals containing different
Pi amounts were served as lunch at 1200 hours, and 100 ml water
was loaded after test meal ingestion per hour. The subjects were
allowed only appointed water and meals after 1400 hours of the
day before. The triangle symbols indicate the time at which blood (m)
and urine (.) samples were collected.
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Figure 2 | Effect of Pi loading (closed circle, P400; open triangle,
P800; open square, P1200) on serum levels of (a) phosphate,
(b) calcium, and (c) creatinine after test meals ingestion. Data are
mean7s.e.m. for eight subjects. *Po0.05 vs P400, wPo0.05 vs P800.
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(P¼ 0.024 vs P800, P¼ 0.002 vs P1200). In addition, the
postprandial peak values after the P1200 meal exceeded the
normal range (2.5–4.5 mg/dl) in seven out of eight subjects.
Urinary Pi excretion gradually increased until 6 h after
ingestion of the P400 meal, and the excretion after P800 and
P1200 meals markedly increased within 1 h compared with
that after P400 (Table 2). As shown in Figure 3a, the
cumulative urinary Pi excretion was significantly increased in
response to Pi loading, the amounts during 8 h after the meal
ingestion were 355726, 455724, and 605718 mg for the
P400, P800, and P1200 meals, respectively (P400 vs P800
(P¼ 0.0058), P400 vs P1200 (Po0.001), P800 vs P1200
(P¼ 0.001)). On the other hand, the fractional renal tubular
reabsorption rate of Pi (% tubular reabsorption of phosphate
(%TRP)) was decreased by Pi loading in a dose-dependent
manner (Figure 3b). After ingestion of the P1200 meal, the
%TRP decreased sharply until 2 h and afterward increased
slightly up to 8 h. Serum levels and urinary excretion of CRE
were not changed during the experimental period in any
subjects (Figure 2c and Table 2).
Measurement of serum Ca, 1,25(OH)2D, and intact-PTH levels
and urinary Ca excretion
Serum Ca levels did not change as the intake of Pi increased
(Figure 2b). As shown in Figure 4a, there were some
significance in the levels of serum 1,25(OH)2D between
different Pi loaded groups, but no dependency on the intake
of Pi amount was observed in serum 1,25(OH)2D levels.
Serum intact-PTH (iPTH) levels at 1, 2, and 4 h after the
P800 and P1200 meals significantly increased compared with
those after the P400 meal (Figure 4b). Time-dependent
changes of serum iPTH levels demonstrated a dual-phase
curve as the intake of Pi increased. The first peak was
observed at 1 h after the meal ingestion, and the second peak
Table 2 | Postprandial changes in urinary excretion
Postprandial
Baseline 1 h 2 h 3 h 4 h 5 h 6 h 7 h 8 h
Pi (mg)
P400 1372.7 2373.9 3474.0* 4574.4* 4673.8* 5575.1* 5773.2* 5073.2* 4573.3*
P800 1171.9 3273.8* 5975.0* 6075.6* 6274.9* 7075.1* 6474.5* 5774.1* 5172.7*
P1200 1272.4 4774.1* 9074.0* 9073.6* 8375.1* 8374.5* 7774.3* 7272.7* 6371.7*
Ca (mg)
P400 1071.4 8.371.4 1171.7 1071.4 9.071.2 6.571.1 4.570.8 3.570.7* 3.570.5*
P800 1171.1 9.370.8 1070.9 8.671.2 7.671.2 5.170.9* 3.770.5* 2.870.5* 2.370.4*
P1200 1071.3 8.471.0 8.471.0 6.971.1 6.571.2 5.071.0* 3.370.6* 2.270.3* 2.070.3*
CRE (mg)
P400 6572.6 6673.6 7273.0 7675.3 7174.1 7173.7 6973.2 6773.8 6774.0
P800 6673.6 6874.0 7373.7 7373.2 7373.4 7072.7 6872.7 6873.3 6673.7
P1200 6473.0 6773.8 7273.5 7373.2 7073.5 7172.7 6872.6 6972.7 6773.9
Ca, calcium; CRE, creatinine; Pi, inorganic phosphate.
Values are mean7s.e.m. for eight subjects.
The baseline values were calculated by dividing the urinary excretion volume collected from 0800 to 1200 hours by 4.
*Po0.01 vs baseline in the same meal.
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Figure 3 | Effect of Pi loading (closed circle, P400; open triangle,
P800; open square, P1200) on (a) the cumulative urinary
excretion of Pi and (b) the fractional renal tubular reabsorption
rate of Pi after test meals ingestion. Data are mean7s.e.m. for
eight subjects. *Po0.05 vs P400, wPo0.05 vs P800.
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Figure 4 | Effect of Pi loading on serum 1,25(OH)2D and iPTH.
Changes from baseline in (a) serum 1,25(OH)2D and (b) serum iPTH
after ingestion of three test meals containing different Pi amounts
(closed circle, P400; open triangle, P800; open square, P1200). Data
were converted to relative changes from baseline as 1, and were
log-transformed for statistical analysis. Values show geometric means
and their standard errors for eight subjects. *Po0.05 vs P400,
wPo0.05 vs P800.
Kidney International (2006) 70, 2141–2147 2143
Y Nishida et al.: Postprandial changes of serum FGF23 o r i g i n a l a r t i c l e
at 6 h. The peak values of iPTH after P1200 were 128711 and
141715% compared with baseline, and at 6 h were also
significantly higher than P400 (P¼ 0.016).
Urinary Ca excretion decreased gradually and significantly
compared with baseline values collected from 0800 hours to
noon in all test meals (Table 2). There was no significant
change in urinary Ca excretion in response to Pi loading in
the comparison of different meals. The cumulative Ca
excretion amounts during 8 h after the meal ingestion were
55.778.5 mg (P400), 49.475.3 mg (P800), and 42.775.8 mg
(P1200).
Effect of oral Pi loading on serum iFGF23 level
Baseline levels of serum iFGF23 in eight subjects varied
within the range of 9–42 pg/ml, but the individual baseline
values at each experimental day were similar (Figure 5a). As
shown in Figure 5b, serum iFGF23 levels after the ingestion
of P400 meal were gradually decreased over the period.
Interestingly, serum iFGF23 levels in the P800 meal were
significantly lower than those in the P400 meal from 1 to 6 h
after the ingestion (Po0.05). After the ingestion of P1200
meal, serum iFGF23 levels were not changed up to 6 h, but
significantly increased at 8 h compared with P400 and P800
meals (Po0.001).
To examine within-individual associations between levels
of the iFGF23 and iPTH, and measures of serum Pi levels and
%TRP, Spearman’s non-parametric correlation coefficients
(rs) were estimated after centralizing biomarker variables by
their median within each individual (see Materials and
Methods section). As shown in Figure 6a and b, significant
negative association was detected between iFGF23 and serum
Pi levels (rs¼0.21, P¼ 0.002), whereas positive association
was observed between iFGF23 and renal Pi reabsorption rate
(%TRP) (rs¼ 0.18, P¼ 0.007). We also carried out similar
analyses, resulting that iPTH levels was significantly asso-
ciated with both serum Pi levels (rs¼ 0.35, Po0.001) and
%TRP (rs¼0.34, Po0.001) (Figure 6c and d).
DISCUSSION
In the present study, we investigated an acute effect of Pi
loading on serum iFGF23 levels in healthy men with
postprandial time-course experiments. We hypothesized that
FGF23 would rapidly respond to Pi loading. However, the
present data demonstrated that serum iFGF23 levels were
decreased or not changed up to 6 h in all diets, but modestly
increased at 8 h after the highest loading (1200 mg).
Interestingly, serum iFGF23 levels after P800 meal were
significantly lower than that of P400 meal. We do not know
the reason, but the data indicated that serum iFGF23 did not
increased in response to Pi loading within 6 h. Additionally,
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Figure 5 | Effect of Pi loading on serum iFGF23 level. (a) Individual
changes in serum iFGF23 in eight subjects from baseline to 8 h. The
same symbol is the same subject in each graph (closed circle, subject
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(b) Relative changes in serum iFGF23 from baseline to 8 h after
ingestion of three test meals containing different Pi amounts
(closed circle, P400; open triangle, P800; open square, P1200).
Data were converted to relative changes from baseline as 1, and
were log-transformed for statistical analysis. Geometric means and
their standard errors for eight subjects are presented. *Po0.05 vs
P400, wPo0.05 vs P800.
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Figure 6 | Univariate association between serum iFGF23 or iPTH,
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serum iFGF23 showed negative correlation with serum Pi
level, but positive correlation with %TRP in this short period
experiment. FGF23 is a phosphaturic factor that strongly
decreases serum Pi level via inhibition of renal Pi reabsorp-
tion.4,9,10 Therefore, there is the discrepancy between the
FGF23 action and relationship between serum iFGF23 levels
and %TRP. On the other hand, we observed significant and
reasonable association of serum iPTH levels with both serum
Pi levels and %TRP. These results suggest that PTH can
rapidly respond to dietary Pi loading but not FGF23.
Larsson et al.15 reported that FGF23 levels did not change
after Pi deprivation or Pi loading. However, they noted that
high levels of FGF23 were found in four of six volunteers on
the high Pi intake. They collected blood samples from their
subjects four times per day at 4 h intervals, and demonstrated
that administration of high doses of Pi failed to trigger a rise
in FGF23, despite significant increases in renal Pi clearance.
Therefore, they suggested that FGF23 is not responsible for
the acute adjustment of Pi excretion in the kidney. Ferrari
et al.19 demonstrated that Pi loading for 3 days increased
serum FGF23 levels in the morning after fasting in spite of
normal serum Pi levels. They also demonstrated that changes
in FGF23 were positively correlated with changes in 24 h
urinary Pi excretion, and negatively correlated with changes
in the maximal Pi reabsorption, but PTH was not.
Additionally, serum FGF23 levels were not correlated with
serum Pi levels in the morning after fasting. Considering
these data, Pi loading was probably involved in the
postprandial increase in serum Pi levels, resulting in increases
in serum FGF23, which reduced serum Pi levels overnight
before the morning sampling. Furthermore, they measured
both intact and C-terminal degradation products of FGF23.
In the morning after fasting, iFGF23 might revert to normal
levels, but C-terminal degradation products might remain
elevated. Therefore, the data may reflect the chronic
adaptation of Pi homeostasis through FGF23 action.
Previous studies demonstrated that dietary Pi loading
increased serum FGF23 levels.17–19,21 What is necessary to
increase serum FGF23 level in response to Pi loading? One
possible explanation is that long-term hyperphosphatemia, as
is often the case in patients with chronic kidney disease,
caused the increase in FGF23 production. Recently, Perwad
et al.18 suggested that dietary Pi loading for 5 days
upregulated serum FGF23 levels in mice. Saito et al.17
demonstrated that ingestion of high Pi diet for 4 weeks
increased both serum Pi and FGF23 level in 5/6 nephrecto-
mized rats. More recent studies also demonstrated that Pi
loading increased serum iFGF23 levels, whereas Pi depletion
decreased serum iFGF23 in human.22,23 These observations
suggest that long-term dietary Pi loading and long-term
hyperphosphatemia would be important regulator under
physiological and pathological conditions. Burnett et al.,23
observed the elevation of serum iFGF23 levels more than 1
day after beginning of the Pi loading (2500 mg diet per day),
but they did not estimate it less than 1 day. On the other
hand, our data suggest that iFGF23 levels cannot rapidly
increase in response to the Pi loading, but increased at 8 h
after the ingestion of P1200 diet. This difference would be
due to the difference of observed period. As far as we know,
there is no report to investigate rapid regulation of FGF23. It
is technically very difficult to carry out the balance study in
rats and mice, especially in short period, because there are
some limitations to correct urine and serum samples every
1 h in such animals. Thus, this is the first report to investigate
the rapid regulation of FGF23 in response to dietary Pi in
detail.
In this study, we hypothesized that the rapid regulation of
Pi homeostasis may be mediated by FGF23 in part. As
described in previous reports,24–26 our results also revealed
that dietary Pi intake acutely decreased renal phosphate
reabsorption (%TRP), and increased serum PTH levels
within 1 h after Pi loading. However, there was only one
time point at 8 h in individuals fed a P1200 meal where
iFGF23 was modestly increased. Despite of the modest
increase in iFGF23 at 6–8 h after Pi loading, tubular Pi
reabsorption slightly increased rather than decreased during
that time. Additionally, opposite correlation between serum
iFGF23 and %TRP was observed. Syal et al.27 reported that
FGF23 increased prostaglandin E2 (PGE2) production in
renal tubular cells to inhibit sodium-dependent Pi transport
activity. This would be an important pathway for the FGF23-
mediated signal. They also demonstrated that FGF23
required 6 h to increase PGE2 production in vivo. Shimada
et al.11 also found that an increase in fractional excretion of
Pi and lower serum Pi level were observed 9 h after the
intravenous injection of FGF23 in vivo. Therefore, the time-
lag of FGF23 action in vivo and the unparallel changes of
serum Pi and iFGF23 we described above may be involved in
the complicated changes in serum iFGF23 levels after dietary
Pi loading within short period.
Unlike FGF23, PTH rapidly, about 1 h, responded to Pi
loading as described previously.24,25 Our data have demons-
trated the double peak response of serum PTH levels to
dietary Pi loading. Recently, Martin et al.20 have demons-
trated that immediate effect of Pi on PTH would not be
dependent on serum Pi increase, suggesting that additional
signal arising from gastrointestinal tract and serum Pi would
contribute to the rapid response. These factors may also
mediate the first peak of serum PTH increase in our result.
On the other hand, the second peak was probably mediated
by serum Pi increase after dietary Pi loading.
In the previous experiment, the subjects were adminis-
tered high Pi diet with high Ca to minimize the response of
PTH to Pi loading.19 Recently, Shimada et al.21 have
suggested that Ca is one of the regulatory factors of FGF23
production in mice. Therefore, high Ca intake could be
required for the induction of FGF23 in response to Pi
loading. In our study, to examine the regulation of FGF23
under a standard Ca intake in Japanese, subjects received a
diet containing Ca standardized to the Japanese recom-
mended daily allowance (about 200 mg per meal) throughout
the study. Therefore, the Pi:Ca ratio in the experimental meal
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was 2:1 in P400, 4:1 in P800, 6:1 in P1200. Ca intake was
therefore relatively lower than that in previous works.19,22,23
Under these conditions, serum iFGF23 did not remarkably
responded to Pi loading in the present study. We cannot
conclude the role of Ca in the regulation of FGF23, but this
study may reflect the physiological FGF23 response to Pi
loading with a standard Japanese diet. Additionally, there is
also no report about diurnal course of FGF23, therefore, the
time-course of P400 would reflect, in part, real diurnal
changes from noon to 2000 hours in our daily life. So we
think that all data in additional Pi loading (P800 and P1200
meals) should be compared with those in P400 meal.
In summary, it has been reported that FGF23 plays an
important role in the phosphate homeostasis. However, our
study demonstrated that serum FGF23 level did not rapidly
increase in response to dietary Pi loading, whereas PTH did.
Our results suggest that FGF23 seemingly has no bearing on
the rapid regulation of Pi homeostasis more than we
expected, although FGF23 probably is a phosphaturic factor
as reported by many papers. There is still more to learn about
the roles of FGF23 and PTH in the regulation of phosphate
homeostasis.
MATERIALS AND METHODS
Subjects
Eight healthy male volunteers between 20 and 34 years of age
without apparent health problems or medication use were recruited
for this study. The study protocols were approved by the Ethics
Committee of the Tokushima University Hospital. Signed written
informed consent was obtained from each study subject before
participation. The baseline characteristics of the eight subjects are
shown in Table 1.
Study design
The protocol utilized in the clearance studies is illustrated
diagrammatically in Figure 1. The study used a randomized,
double-blind, crossover design on 3 different days separated by at
least 7 days. The subjects were alternately served one of three test
meals containing different Pi amounts adjusted by Pi supplement as
lunch at noon. The test meals were as follows: (1) P400, standard
meal containing 400 mg Pi and placebo supplement; (2) P800,
standard meal and a 400 mg Pi supplement; and (3) P1200, standard
meal and a 800 mg Pi supplement. The standard meal consisted of
steamed rice, boiled egg, ham, and milk (690 kcal, 110 g carbo-
hydrate, 23 g protein, 16 g fat, 400 mg Pi, and 200 mg Ca). Pi
supplement was administered orally as a solution of neutral sodium
phosphate (mixture of Na2HPO4 and NaH2PO4). To keep the
intakes of Na constant among three test meals, the amount of Na in
each placebo and Pi supplement was adjusted to 1022 mg by NaCl
(for P400, placebo supplement contained 1022 mg Na as NaCl; for
P800, 400 mg Pi supplement contained 511 mg Na in NaCl and
511 mg Na in sodium phosphate; for P1200, 800 mg Pi supplement
contained 1022 mg Na in sodium phosphate). The subjects drank
each supplement dissolved in 22 ml water in the same time during a
meal. All of the meals were consumed over 7–14 min. The subjects
remained sedentary during the experimental period and drank the
appointed water (100 ml/h) only. Before each study day, the subjects
were asked to abstain from foods and beverages other than water,
not containing Pi, after 1400 hours. They were served a standard
dinner (650 kcal, 100 g carbohydrate, 23 g protein, 16 g fat, 480 mg
Pi, and 250 mg Ca) at 2000 hours, and instructed to go to bed at
2400 hours. On each study day, the subjects consumed a standard
breakfast (620 kcal, 110 g carbohydrate, 22 g protein, 14 g fat, 330 mg
Pi, and 200 mg Ca) after urination at 0800 hours. Urine was
collected from 0800 to 1200 hours, as a baseline sample.
Blood samples were collected immediately before (0 h; baseline)
and at 0.5, 1, 1.5, 2, 3, 4, 6, and 8 h after test meal ingestion. Venous
blood was taken from an antecubital vein for the measurement of
serum Pi, Ca, CRE, 1,25(OH)2D, iPTH, and iFGF23 concentrations.
Aliquots of serum were stored at 801C until assayed. Urine samples
after test meal ingestion were also collected every hour from noon to
2000 hours, and volumes were recorded. All urine samples were
stored at 301C until assayed. We measured urinary concentrations
of Pi, Ca, and CRE.
Biochemical determinations
Serum and urinary concentrations of Pi, Ca, and CRE were
measured using each specific assay kit (Wako Pure Chemical
Industries Ltd, Osaka, Japan). Serum 25-hydroxyvitamin D,
1,25(OH)2D, and iPTH were analyzed by MBC (Mitsubishi Kagaku
Bio-Clinical Laboratories Inc., Tokyo, Japan) using a radioimmu-
noassay and an immunoradiometric assay, respectively. The
fractional renal tubular reabsorption rate of Pi (%TRP) was
calculated from the equation %TRP¼ 100 (1(urine Pi concen-
tration serum CRE concentration/urine CRE concentra-
tion serum Pi concentration)).
Determination of serum FGF23 levels
FGF23 can be processed by proteases to release a small C-terminal
peptide. The C-terminal proteolytic peptide may complicate the
evaluation of iFGF23.28 Recent publication by Burnett et al.23
pointed out that iFGF23 can more precisely reflect physiological
response than C-terminal FGF23. Therefore, we have used intact
FGF23 kit (Kainos Laboratories Inc., Tokyo, Japan) for this
investigation and this is reasonable for the evaluation of FGF23
status in our experiment.
Statistics
To examine the time-course behaviors, we performed mixed model
regression analysis to consider repeated measures of crossover
setting. In the regression analyses, one of serum and urinary
biomarkers was included as a dependent variable; and time, Pi
loading levels, time–Pi interaction were included as independent
variables. We considered it appropriate for our analyses to use Pi
loading level as a categorical variable, resulted from likelihood ratio
tests comparing regression models with Pi loading levels treated as
continuous or categorical variable. Therefore, mainly Pi loading
levels were treated as categorical. With respect to assumptions of
regression analysis and goodness-to-fit by examination of distribu-
tion normality, Akaike Information Criteria, and properties of
residuals from mixed model, we decided to use the data on log-
transformed relative changes in levels of serum iFGF23, serum 1,25-
(OH)2D, and serum PTH, the data on absolute changes in levels of
%TRP, and the crude data on levels of serum calcium, serum Pi, and
serum CRE. When results derived from log-transformed data,
geometric means and their standard errors were presented. In the
analyses with dependent variables representing relative or absolute
changes, the effect of statistical adjustment for baseline value of
outcome measures was considered to account for the differences in
baseline values. Results with and without the adjustment were little
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different (data not shown). Therefore, in all regression models, we
included the variable representing the baseline values to avoid
potential bias due to variability of baseline values.
To examine associations between levels of iFGF23 and PTH, and
measures of serum Pi levels and %TRP, Spearman’s non-parametric
correlation coefficients were estimated. Non-parametric procedure
was selected to avert requirements of normal distributions and
linear associations of variables of interests. To quantify the
associations between biomarkers in acute response to Pi loading
within each individual, estimated correlations need to be indepen-
dent of between-individual variability. Hence, we centralized each
biomarker variable within each individual by median value so that
correlation statistics were independent of between-individual
variability. Here, results of Spearman’s correlation coefficients from
data median-centralized within each individual are shown in this
paper.
We also applied one-way analysis of variance to compare values
for the AUC for serum Pi calculated over 8 h (AUC comparison) and
cumulative urinary Pi excretion with consequence post hoc Fisher’s
PLSD comparisons for the AUC comparison.
In our analyses, two-sided P-values were estimated. We regarded
P-value less than 0.05 statistically significant. Statistical analyses were
performed by SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
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